Astera Labs (NASDAQ:ALAB) Issues Earnings Results

Astera Labs (NASDAQ:ALAB) issued its quarterly earnings data on Tuesday. The company reported $0.26 earnings per share for the quarter, missing analysts’ consensus estimates of $0.39 by ($0.13), Zacks reports. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. Astera Labs updated its Q4 2025 guidance to 0.50-0.510 EPS.

Astera Labs Trading Down 6.4%

Shares of Astera Labs stock traded down $12.25 during trading hours on Tuesday, hitting $179.31. 8,765,759 shares of the company were exchanged, compared to its average volume of 5,234,111. The business has a 50-day moving average of $196.78 and a 200-day moving average of $137.86. Astera Labs has a 1 year low of $47.13 and a 1 year high of $262.90. The stock has a market capitalization of $29.80 billion, a price-to-earnings ratio of 320.20, a P/E/G ratio of 4.66 and a beta of 1.38.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on ALAB shares. Susquehanna boosted their price objective on Astera Labs from $80.00 to $125.00 and gave the company a “neutral” rating in a research note on Thursday, August 7th. Needham & Company LLC boosted their price objective on Astera Labs from $100.00 to $170.00 and gave the company a “buy” rating in a research note on Wednesday, August 6th. Zacks Research cut Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 6th. Citigroup upped their price target on Astera Labs from $160.00 to $275.00 and gave the stock a “buy” rating in a research note on Wednesday, September 17th. Finally, Evercore ISI upped their price target on Astera Labs from $104.00 to $215.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 6th. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $162.06.

Insider Activity

In related news, Director Stefan A. Dyckerhoff sold 25,000 shares of the company’s stock in a transaction on Thursday, August 7th. The stock was sold at an average price of $173.42, for a total transaction of $4,335,500.00. Following the transaction, the director owned 99,154 shares of the company’s stock, valued at $17,195,286.68. This represents a 20.14% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Jitendra Mohan sold 152,517 shares of the company’s stock in a transaction on Thursday, August 7th. The stock was sold at an average price of $170.33, for a total value of $25,978,220.61. Following the transaction, the chief executive officer directly owned 450,001 shares in the company, valued at $76,648,670.33. This represents a 25.31% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 1,092,997 shares of company stock valued at $192,231,120 over the last three months. 12.50% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Thrivent Financial for Lutherans acquired a new position in Astera Labs during the second quarter worth $592,000. Advisory Services Network LLC acquired a new position in Astera Labs during the second quarter worth $692,000. Geneos Wealth Management Inc. grew its holdings in Astera Labs by 121.2% during the second quarter. Geneos Wealth Management Inc. now owns 8,920 shares of the company’s stock worth $807,000 after acquiring an additional 4,887 shares during the period. Public Sector Pension Investment Board grew its holdings in Astera Labs by 196.0% in the second quarter. Public Sector Pension Investment Board now owns 296,000 shares of the company’s stock valued at $26,764,000 after purchasing an additional 196,000 shares during the last quarter. Finally, Tower Research Capital LLC TRC increased its position in shares of Astera Labs by 506.3% in the second quarter. Tower Research Capital LLC TRC now owns 2,486 shares of the company’s stock valued at $225,000 after buying an additional 2,076 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.